Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Study Identifier
M10-277
CT.gov Identifier
NCT00763321
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Pain
    • Study Drug
  • ABT-712
  • Placebo
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    21 - 75 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Adult male and female subjects who voluntarily sign the informed consent * Diagnosis of CLBP of 6 months duration
    Exclusion Criteria:
    * Incapacitated or bedridden subjects * Subjects with history of surgical or invasive intervention

    Protocol Summary

    The primary purpose of the study is to test the efficacy of 2 tablets (twice daily) of ABT-712, compared to placebo, administered over a 4-week period in participants with moderate to severe mechanical chronic low back pain (CLBP).

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 10044
    Huntsville, Alabama, United States, 35801
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10070
    Burbank, California, United States, 91505
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10050
    San Diego, California, United States, 92108
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10060
    Atlantis, Florida, United States, 33462
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10069
    Hollywood, Florida, United States, 33023
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10045
    Kissimmee, Florida, United States, 347411
    Status
    Not applicable
    Showing {first} - {last} of {total} Results